Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan's Tribe Deal Over Restasis Sparks Ire From Legislators

Sep 28 2017

• By Jessica Merrill

The fight over the Affordable Care Act and the repeal and replace of Obamacare concept.In American politics US parties are represented by either the democrat donkey or republican elephant

Related Content

Allergan Seeks Quick Vraylar Turnaround After US FDA Refuses To File

Sep 26 2017

Too Bold By Half: Allergan’s Latest Moves And Pharma’s Leadership Deficit

Sep 12 2017

Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR

Sep 09 2017

Allergan’s Two-Year NASH Data Fail To Show Fibrosis Benefit

Sep 22 2017

Mylan Calls Allergan Restasis Patent Deal A 'Desperate Tactic'

Sep 13 2017

Related Companies

Allergan plc

Viatris Inc.

Additional Topics

Intellectual Property Legal Issues Generic Drugs Commercial BioPharmaceutical

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.